P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA

• Philippe Moreau,
• Niels W.C.J. van de Donk,
• Michel Delforge,
• Hermann Einsele,
• Valerio De Stefano,
• Aurore Perrot,
• Britta Besemer,
• Charlotte Pawlyn,
• Lionel Karlin,
• Salomon Manier,
• Xavier Leleu,
• Pushpike Thilakarathne,
• Joris Diels,
• Katharine Gries,
• Nichola Erler-Yates,
• Kirsten van Nimwegen,
• Raúl Morano,
• Vadim Strulev,
• Imene Haddad,
• Rachel Kobos,
• Jennifer Smit,
• Alexander Marshall,
• Mary Slavcev,
• Maria-Victoria Mateos,
• Katja Weisel

Affiliations

Philippe Moreau

1 University Hospital Hotel-Dieu, Nantes, France

Niels W.C.J. van de Donk

2 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

Michel Delforge

3 University of Leuven, Leuven, Belgium

Hermann Einsele

4 Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Valerio De Stefano

5 Catholic University, Fondazione Policlinico A. Gemelli, IRCCS, Rome, Italy

Aurore Perrot

6 Centre Hospitalier Universitaire de Toulouse, Service d’Hématologie,, Toulouse, France

Britta Besemer

8 University of Tübingen, Tübingen, Germany

Charlotte Pawlyn

9 The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom

Lionel Karlin

10 Centre Hospitalier Lyon Sud, France

Salomon Manier

12 University of Lille, Lille, France

Xavier Leleu

13 CHU Poitiers, Poitiers, France

Pushpike Thilakarathne

14 Janssen Pharmaceutica NV, Beerse, Belgium

Joris Diels

14 Janssen Pharmaceutica NV, Beerse, Belgium

Katharine Gries

15 Janssen Research & Development, Raritan, United States

Nichola Erler-Yates

16 Janssen-Cilag GmbH, Neuss, Germany

Kirsten van Nimwegen

17 Janssen-Cilag Benelux, Breda, The Netherlands

Raúl Morano

18 Janssen-Cilag, Madrid, Spain

Vadim Strulev

14 Janssen Pharmaceutica NV, Beerse, Belgium

Imene Haddad

19 Janssen-Cilag, Issy-les-Moulineaux, France

Rachel Kobos

20 Janssen Research & Development, Raritan, United States

Jennifer Smit

21 Janssen Research & Development, Spring House, United States

Alexander Marshall

15 Janssen Research & Development, Raritan, United States

Mary Slavcev

22 Janssen Global Services, Raritan, United States

Maria-Victoria Mateos

23 Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBASL), Centro de Investigación del Cáncer (IBMCC-USAL,CSIC), Salamanca, Spain

Katja Weisel

24 University Medical Center Hamburg-Eppendorf, Hamburg, Germany